Correlation Between Cullinan Oncology and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Neoleukin Therapeutics, you can compare the effects of market volatilities on Cullinan Oncology and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Neoleukin Therapeutics.
Diversification Opportunities for Cullinan Oncology and Neoleukin Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cullinan and Neoleukin is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Neoleukin Therapeutics
If you would invest 69.00 in Neoleukin Therapeutics on September 24, 2024 and sell it today you would earn a total of 0.00 from holding Neoleukin Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Cullinan Oncology LLC vs. Neoleukin Therapeutics
Performance |
Timeline |
Cullinan Oncology LLC |
Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cullinan Oncology and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cullinan Oncology and Neoleukin Therapeutics
The main advantage of trading using opposite Cullinan Oncology and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.Cullinan Oncology vs. Fate Therapeutics | Cullinan Oncology vs. Sana Biotechnology | Cullinan Oncology vs. Caribou Biosciences | Cullinan Oncology vs. Arcus Biosciences |
Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |